Eli Lilly & Co. (LLY): Price and Financial Metrics

LLY POWR Grades

• Quality is the dimension where LLY ranks best; there it ranks ahead of 92.4% of US stocks.
• LLY's strongest trending metric is Value; it's been moving down over the last 179 days.
• LLY ranks lowest in Momentum; there it ranks in the 8th percentile.

LLY Stock Summary

• With a market capitalization of $274,647,387,667, ELI LILLY & Co has a greater market value than 99.41% of US stocks.
• ELI LILLY & Co's stock had its IPO on January 1, 1986, making it an older stock than 92.84% of US equities in our set.
• Price to trailing twelve month operating cash flow for LLY is currently 37.83, higher than 85.92% of US stocks with positive operating cash flow.
• Stocks with similar financial metrics, market capitalization, and price volatility to ELI LILLY & Co are PFE, ABBV, MRK, NVO, and NVS.
• Visit LLY's SEC page to see the company's official filings. To visit the company's web site, go to www.lilly.com.

LLY Valuation Summary

• LLY's price/earnings ratio is 40.7; this is 11.51% higher than that of the median Healthcare stock.
• Over the past 243 months, LLY's price/earnings ratio has gone up 13.
• LLY's price/earnings ratio has moved up 13 over the prior 243 months.

Below are key valuation metrics over time for LLY.

LLY Growth Metrics

Its year over year net income to common stockholders growth rate is now at 10.11%.
• Its 4 year net cashflow from operations growth rate is now at 93.93%.
• Its 3 year revenue growth rate is now at 18.68%.

Over the past 34 months, LLY's revenue has gone up $4,370,500,000.

The table below shows LLY's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	28,318.4	7,260.7	5,581.7
2021-09-30	27,758.5	6,919.4	5,972.4
2021-06-30	26,726.3	7,094.7	6,070.7
2021-03-31	25,485.6	7,814.6	6,092.5
2020-12-31	24,539.8	6,499.6	6,193.7
2020-09-30	23,213.8	6,648.1	5,572.6

LLY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• LLY has a Quality Grade of B, ranking ahead of 90.11% of graded US stocks.
• LLY's asset turnover comes in at 0.586 -- ranking 60th of 681 Pharmaceutical Products stocks.
• BHC, VRTX, and DRRX are the stocks whose asset turnover ratios are most correlated with LLY.

The table below shows LLY's key quality metrics over time.